The role of inflammatory modulators in the induction of Hippocampal Sclerosis in patients with Temporal Lobe Epilepsy

Authors

DOI:

https://doi.org/10.33448/rsd-v13i11.47087

Keywords:

Inflammation; Neuroinflammation; Temporal lobe epilepsy; Hippocampal sclerosis.

Abstract

Temporal lobe epilepsy (TLE) is a common neurological syndrome characterized by refractory seizures, often associated with hippocampal sclerosis (HS). Understanding the inflammatory mechanisms in TLE is essential for developing more effective treatments, especially for cases that do not respond to conventional therapies. With the aim of investigating the relationship between neuroinflammation and TLE with HS, a systematic review was conducted following PRISMA guidelines, with a final sample of 10 articles from 2019 to 2024 available in the Virtual Health Library (VHL). The results showed that neuroinflammation, mediated by cytokines such as IL-1β, IL-6, and the protein HMGB1, exacerbates epileptic seizures. The activation of NLRP1 and NLRP3 inflammasomes, and the immune response of microglia and astrocytes, are linked to neuronal degeneration in the hippocampus. Neuroinflammation affects the integrity of hippocampal tissue, neurogenesis, and synaptic plasticity, leading to cognitive deficits. Thus, modulating inflammatory pathways emerges as a potential therapeutic strategy to reduce seizures and preserve cognitive function, but further studies are needed to optimize clinical management.

References

Aguilar-Castillo, M. J., Cabezudo-García, P., García-Martín, G., Lopez-Moreno, Y., Estivill-Torrús, G., Ciano-Petersen, N. L., ... & Serrano-Castro, P. J. (2024). A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis. International Journal of Molecular Sciences, 25(12), 6488.

Aulická, S., Česká, K., Šána, J., Siegl, F., Brichtová, E., Ošlejšková, H., ... & Nestrašil, I. (2022). Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Epilepsy Research, 180, 106858.

Basnyat, P., Pesu, M., Söderqvist, M., Grönholm, A., Liimatainen, S., Peltola, M., Raitanen, J., & Peltola, J. (2020). Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients. BMC neurology, 20(1), 241. https://doi.org/10.1186/s12883-020-01825-x

De Brito Toscano, E. C., Vieira, É. L. M., Dias, B. B. R., Caliari, M. V., Gonçalves, A. P., Giannetti, A. V., ... & Teixeira, A. L. (2021). NLRP3 and NLRP1 inflammasomes are up-regulated in patients with mesial temporal lobe epilepsy and may contribute to overexpression of caspase-1 and IL-β in sclerotic hippocampi. Brain Research, 1752, 147230.

Horta W G. (2020). Neuroinflamação na perpetuação da epilepsia do lobo temporal associado à esclerose hipocampal (ELT-EH). Silva Neto BR, editor. Frente diagnóstica e terapêutica na neurologia 1 [recurso eletrônico]. Ponta Grossa: Atena Editora; 2020. Cap. 13.

Lakatos, E M e Marconi, M A (2017). Fundamentos de metodologia científica.

Langenbruch, L., Bleß, L., Schulte‐Mecklenbeck, A., Sundermann, B., Brix, T., Elger, C. E., ... & Kovac, S. (2020). Blood and cerebrospinal fluid immune cell profiles in patients with temporal lobe epilepsy of different etiologies. Epilepsia, 61(10), e153-e158.

Lisman, J. E., & Grace, A. A. (2005). The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron, 46(5), 703-713.

Liu, Q., Shen, C., Dai, Y., Tang, T., Hou, C., Yang, H., ... & Zhao, G. (2024). Single-cell, single-nucleus and xenium-based spatial transcriptomics analyses reveal inflammatory activation and altered cell interactions in the hippocampus in mice with temporal lobe epilepsy. Biomarker Research, 12(1), 1-19.

Martins-Ferreira, R., Leal, B., Chaves, J., Li, T., Ciudad, L., Rangel, R., ... & Ballestar, E. (2022). Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes. Progress in Neurobiology, 209, 102207.

Patients

Rácz, A., Hummel, C. A., Becker, A., Helmstaedter, C., Schuch, F., Baumgartner, T., ... & Elger, C. E. (2022). Histopathologic characterization and neurodegenerative markers in with limbic encephalitis undergoing epilepsy surgery. Frontiers in Neurology, 13, 859868

Riney, K., Bogacz, A., Somerville, E., Hirsch, E., Nabbout, R., Scheffer, I. E., ... & Tinuper, P. (2022). International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 63(6), 1443-1474.

Tan, C. C., Zhang, J. G., Tan, M. S., Chen, H., Meng, D. W., Jiang, T., ... & Tan, L. (2015). NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model. Journal of neuroinflammation, 12, 1-12.

Tezer, F. I., Xasiyev, F., Soylemezoglu, F., Bilginer, B., Oguz, K. K., & Saygi, S. (2016). Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the recent histopathological classifications. Epilepsy research, 127, 50-54.

Tröscher, A. R., Mair, K. M., Verdú de Juan, L., Köck, U., Steinmaurer, A., Baier, H., ... & Bien, C. G. (2023). Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex. Brain, 146(4), 1436-1452.

Ulusoy, C., Vanlı-Yavuz, E. N., Şanlı, E., Timirci-Kahraman, Ö., Yılmaz, V., Bebek, N., Küçükali, C. İ., Baykan, B., & Tüzün, E. (2020). Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes. Journal of Neuroimmunology, 347(577343), 577343.

Vieira, É. L. M., Martins, F. M. A., Bellozi, P. M. Q., Gonçalves, A. P., Siqueira, J. M., Gianetti, A., ... & de Oliveira, A. C. P. (2021). PI3K, mTOR and GSK3 modulate cytokines’ production in peripheral leukocyte in temporal lobe epilepsy. Neuroscience Letters, 756, 135948.

Wen, W., Zhou, J., Zhan, C. A., & Wang, J. (2024). Microglia as a game changer in epilepsy comorbid depression. Molecular Neurobiology, 61(7), 4021-4037.

World Health Organization. (2006). Neurological disorders: public health challenges. World Health Organization.

Zaben, M., Haan, N., Sharouf, F., Ahmed, A., Sundstrom, L. E., & Gray, W. P. (2021). IL-1β and HMGB1 are anti-neurogenic to endogenous neural stem cells in the sclerotic epileptic human hippocampus. Journal of neuroinflammation, 18, 1-15.

Published

17/11/2024

How to Cite

DAMASCENO, M. I. S. .; MCGILL, S. M. S. .; ALMEIDA, G. D. P. de .; LEÃO, C. V. .; MOURA, R. M. de A. .; ARAÚJO, A. B. C. .; HORTA, W. G. . The role of inflammatory modulators in the induction of Hippocampal Sclerosis in patients with Temporal Lobe Epilepsy. Research, Society and Development, [S. l.], v. 13, n. 11, p. e104131147087, 2024. DOI: 10.33448/rsd-v13i11.47087. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/47087. Acesso em: 26 nov. 2024.

Issue

Section

Health Sciences